- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
NICE Guidelines for Bladder Cancer Can Minimize Care Variance
NICE's first guideline on bladder cancer aims to improve the diagnosis and management of the seventh most common cancer in the UK.
There are just over 10,000 cases of bladder cancer diagnosed each year, according to figures from Cancer Research UK. It is 3—4 times more common in men than in women.
The majority of cases occur in people aged over 60, with age being the main risk factor for bladder cancer. Smoking and exposure to some industrial chemicals - such as those used in the rubber and dye industries — can also increase the risk.
Due to the number of people with the disease, the intensive treatment sometimes needed and the prolonged follow-up often done, it is thought to be one of the most expensive cancers for the NHS, but there is a wide variation across the country in terms of the treatments offered.
Link to the complete article:
Source: National Institute for Health and Care Excellence
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Texas Oncology to Roll Out Canopy for ePROs After Head-to-Head Pilot
March 18th 2025Debra Patt, MD, PhD, MBA, executive vice president of Public Policy and Strategy for Texas Oncology, said the practice received positive feedback from nurses and patients during a pilot that concluded in February.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
